Japan related Press Releases
Celgene Announces New Drug Application Filing for REVLIMID in Japan
Celgene Announces New Drug Application Filing for REVLIMID® in Japan REVLIMID filing based on safety and efficacy results of two large, randomised pivotal Phase III trials, as well as specific... Read more...
Shire Announces Opening of Office in Japan
Shire Announces Opening of Office in Japan TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty... Read more...
Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin
Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin in Japan PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Bristol-Myers
... Read more...Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b)
Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b Vaccine) Available in Japan on December 19, 2008 LYON, France, November
... Read more...MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production
MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production GAITHERSBURG, Md., Sept 29, 2008 /PRNewswire via COMTEX News Network/ --... Read more...
Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal
Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal September 25, 2008 WHITEHOUSE STATION, N.J. & TOKYO--(BUSINESS WIRE)--Merck & Co., Inc. and Japan Tobacco Inc. (JT)... Read more...
Teva and Kowa Announce Strategic Partnership to Create a Leading Generic Pharmaceutical Company in Japan
Teva and Kowa Announce Strategic Partnership to Create a Leading Generic Pharmaceutical Company in Japan Goal to Reach Sales of $1 Billion in 2015 Jerusalem, Israel, and Tokyo, Japan, September 24,... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




